• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»Synaffix

Can bispecific ADCs give NEOK Bio a more credible route into solid tumor drug development?

By Pallavi Madhiraju on April 18, 2026   Pharma & Biotech  

Can bispecific ADCs give NEOK Bio a more credible route into solid tumor drug development?

NEOK Bio unveiled AACR 2026 data for NEOK001 and NEOK002. Read how its bispecific ADC strategy could reshape solid tumor competition.

Recent Posts

  • Why Gilead’s Arcellx acquisition approval could reshape the multiple myeloma CAR-T race
  • Can PreludeDx and Quanterix turn AidaBREAST into a new standard for radiation therapy decisions
  • Why everyone watching neurology at AAN 2026 may end up talking about Acadia Pharmaceuticals
  • Salubris Biotherapeutics expands JK06 data at AACR 2026 with encouraging responses in difficult solid tumors
  • Can OncoNano Medicine’s ON-BOARD platform solve antigen limits in solid tumor drug delivery?
  • Can Orum Therapeutics crack one of AML’s hardest problems with ORM-1153? AACR 2026 data spark fresh attention
  • How NEU-002 could reshape Onchilles Pharma’s systemic solid tumor strategy after AACR 2026
  • Is CD39 finally ready for a breakout moment in lung cancer? Innate Pharma tests the thesis
  • Can bispecific ADCs give NEOK Bio a more credible route into solid tumor drug development?
  • AACR 2026: SingleCell Biotechnology targets oncology’s blind spot with functional single-cell profiling
  • Can Zai Lab’s ZL-1503 turn dual-pathway itch control into a real atopic dermatitis advantage?
  • IntoDNA unveils sSTRIDE-NER and sSTRIDE-PARP1 at AACR 2026, can functional DNA repair assays reshape precision oncology?
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes